AAAAAA

   
Results: 1-25 | 26-50 | 51-57
Results: 1-25/57
SIL-2R AS A DIAGNOSTIC-TOOL FOR ACUTE GVHD AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: REMBERGER M RINGDON O
Citation: M. Remberger et O. Ringdon, SIL-2R AS A DIAGNOSTIC-TOOL FOR ACUTE GVHD AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, European cytokine network, 9(3), 1998, pp. 40-40
TOXICITY OF ELEMENTAL SULFUR IN SEDIMENTS
Authors: SVENSON A VIKTOR T REMBERGER M
Citation: A. Svenson et al., TOXICITY OF ELEMENTAL SULFUR IN SEDIMENTS, Environmental toxicology and water quality, 13(3), 1998, pp. 217-224
RISK-FACTORS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA - INCREASED RELAPSE RISK IN PATIENTS TREATED WITH CIPROFLOXACIN FOR GUT DECONTAMINATION
Authors: CARLENS S RINGDEN O ASCHAN J HAGGLUND H LJUNGMAN P MATTSSON J REMBERGER M
Citation: S. Carlens et al., RISK-FACTORS IN BONE-MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA - INCREASED RELAPSE RISK IN PATIENTS TREATED WITH CIPROFLOXACIN FOR GUT DECONTAMINATION, Clinical transplantation, 12(2), 1998, pp. 84-92
RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS
Authors: CARLENS S RINGDEN O REMBERGER M LONNQVIST B HAGGLUND H KLAESSON S MATTSSON J SVAHN BM WINIARSKI J LJUNGMAN P ASCHAN J
Citation: S. Carlens et al., RISK-FACTORS FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE SINGLE-CENTER ANALYSIS, Bone marrow transplantation, 22(8), 1998, pp. 755-761
BACTEREMIA DURING THE APLASTIC PHASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH EARLY DEATH FROM INVASIVE FUNGAL INFECTION
Authors: SPARRELID E HAGGLUND H REMBERGER M RINGDEN O LONNQVIST B LJUNGMAN P ANDERSSON J
Citation: E. Sparrelid et al., BACTEREMIA DURING THE APLASTIC PHASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH EARLY DEATH FROM INVASIVE FUNGAL INFECTION, Bone marrow transplantation, 22(8), 1998, pp. 795-800
FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO DIFFERENCES IN ACUTE GVHD OR SURVIVAL, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW
Authors: HAGGLUND H RINGDEN O REMBERGER M LONNQVIST B SPARRELID E TAMMIK L KUMLIEN G
Citation: H. Hagglund et al., FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO DIFFERENCES IN ACUTE GVHD OR SURVIVAL, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW, Bone marrow transplantation, 22(2), 1998, pp. 131-136
BOOSTER MARROW OR BLOOD-CELLS FOR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: REMBERGER M RINGDEN O LJUNGMAN P HAGGLUND H WINIARSKI J LONNQVIST B ASCHAN J
Citation: M. Remberger et al., BOOSTER MARROW OR BLOOD-CELLS FOR GRAFT FAILURE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 22(1), 1998, pp. 73-78
INTRAOSSEOUS COMPARED TO INTRAVENOUS-INFUSION OF ALLOGENEIC BONE-MARROW
Authors: HAGGLUND H RINGDEN O AGREN B WENNBERG L REMBERGER M RUNDQUIST L SVAHN BM ASPELIN P
Citation: H. Hagglund et al., INTRAOSSEOUS COMPARED TO INTRAVENOUS-INFUSION OF ALLOGENEIC BONE-MARROW, Bone marrow transplantation, 21(4), 1998, pp. 331-335
OUTCOME OF ALLOGENEIC PBPC COMPARED TO BONE-MARROW FROM RELATED AND UNRELATED DONORS
Authors: HAGGLUND H RINGDEN O LONNQVIST B SPARRELID E REMBERGER M KUMLIEN G
Citation: H. Hagglund et al., OUTCOME OF ALLOGENEIC PBPC COMPARED TO BONE-MARROW FROM RELATED AND UNRELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 42-42
TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE
Authors: RINGDEN O REMBERGER M MATTSSON J ASCHAN J CARLENS S HAGGLUND H LONNQVIST B SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE, Bone marrow transplantation, 21(1), 1998, pp. 43-49
CADAVERIC BONE-MARROW AND SPLEEN-CELLS FOR TRANSPLANTATION
Authors: SODERDAHL G TAMMIK C REMBERGER M RINGDEN O
Citation: G. Soderdahl et al., CADAVERIC BONE-MARROW AND SPLEEN-CELLS FOR TRANSPLANTATION, Bone marrow transplantation, 21(1), 1998, pp. 79-84
A PROSPECTIVE RANDOMIZED TRIAL GIVING G-CSF AT DIFFERENT TIMES AFTER UNRELATED BMT
Authors: HAGGLUND H RINGDEN O OHMAN S REMBERGER M CARLENS S MATTSSON J
Citation: H. Hagglund et al., A PROSPECTIVE RANDOMIZED TRIAL GIVING G-CSF AT DIFFERENT TIMES AFTER UNRELATED BMT, Bone marrow transplantation, 21, 1998, pp. 113-113
LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A, HLA-B, AND HLA-DR IDENTICAL DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES
Authors: RINGDEN O REMBERGER M CARLENS S HAGGLUND H MATTSSON J ASCHAN J LONNQVIST B KLAESSON S WINIARSKI J DALIANIS T OLERUP O SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A, HLA-B, AND HLA-DR IDENTICAL DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES, Bone marrow transplantation, 21, 1998, pp. 114-114
FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO INCREASE IN ACUTE GVHD, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW
Authors: HAGGLUND H RINGDEN O REMBERGER M LONNQVIST B SPARRELID E TAMMIK L KUMLIEN G
Citation: H. Hagglund et al., FASTER NEUTROPHIL AND PLATELET ENGRAFTMENT, BUT NO INCREASE IN ACUTE GVHD, USING PERIPHERAL-BLOOD STEM-CELLS FROM RELATED AND UNRELATED DONORS, COMPARED TO BONE-MARROW, Bone marrow transplantation, 21, 1998, pp. 143-143
IMMUNOSUPPRESSIVE EFFECTS OF RAPAMYCIN
Authors: REMBERGER M TAMMIK L RINGDEN O
Citation: M. Remberger et al., IMMUNOSUPPRESSIVE EFFECTS OF RAPAMYCIN, Bone marrow transplantation, 21, 1998, pp. 366-366
LOW-DOSE CYCLOSPORINE PROPHYLAXIS DOES NOT INCREASE THE RISK OF SEVERE ACUTE GVHD IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA
Authors: CARLENS S ASCHAN J REMBERGER M RINGDEN O
Citation: S. Carlens et al., LOW-DOSE CYCLOSPORINE PROPHYLAXIS DOES NOT INCREASE THE RISK OF SEVERE ACUTE GVHD IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA, Bone marrow transplantation, 21, 1998, pp. 414-414
CLINICAL EFFECTS OF INTRAVENOUS IMMUNE GLOBULIN TREATMENT AFTER BONE-MARROW TRANSPLANTATION, USING HLA MATCHED UNRELATED DONORS
Authors: KLAESSON S HAGGLUND H LJUNGMAN P CARLENS S MATTSSON J REMBERGER M SPARRELID E WINIARSKI J RINGDEN O
Citation: S. Klaesson et al., CLINICAL EFFECTS OF INTRAVENOUS IMMUNE GLOBULIN TREATMENT AFTER BONE-MARROW TRANSPLANTATION, USING HLA MATCHED UNRELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 415-415
LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-COMPATIBLE, HLA-B-COMPATIBLE, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING, ANTI-T-CELL ANTIBODIES
Authors: RINGDEN O REMBERGER M CARLENS S HAGGLUND H MATTSSON J ASCHAN J LONNQVIST B KLAESSON S WINIARSKI J DALIANIS T OLERUP O SPARRELID E ELMHORNROSENBORG A SVAHN BM LJUNGMAN P
Citation: O. Ringden et al., LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-COMPATIBLE, HLA-B-COMPATIBLE, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING, ANTI-T-CELL ANTIBODIES, Transplantation, 66(5), 1998, pp. 620-625
INCREASED SERUM CONCENTRATIONS OF INTERLEUKIN-2 RECEPTOR IN THE FIRST-TRIMESTER IN WOMEN WHO LATER DEVELOPED SEVERE PREECLAMPSIA
Authors: ENEROTH E REMBERGER M VAHLNE A RINGDEN O
Citation: E. Eneroth et al., INCREASED SERUM CONCENTRATIONS OF INTERLEUKIN-2 RECEPTOR IN THE FIRST-TRIMESTER IN WOMEN WHO LATER DEVELOPED SEVERE PREECLAMPSIA, Acta obstetricia et gynecologica Scandinavica, 77(6), 1998, pp. 591-593
BROAD-SPECTRUM ANALYSIS OF A CONTAMINATED SEDIMENT - EXEMPLIFICATION OF A PROTOCOL
Authors: HYNNING PA REMBERGER M NEILSON AH KIPPS M STANLEY P
Citation: Pa. Hynning et al., BROAD-SPECTRUM ANALYSIS OF A CONTAMINATED SEDIMENT - EXEMPLIFICATION OF A PROTOCOL, Journal of chromatography, 774(1-2), 1997, pp. 311-319
RISK-FACTORS FOR SALIVARY DYSFUNCTION IN CHILDREN 1-YEAR AFTER BONE-MARROW TRANSPLANTATION
Authors: DAHLLOF G BAGESUND M REMBERGER M RINGDEN O
Citation: G. Dahllof et al., RISK-FACTORS FOR SALIVARY DYSFUNCTION IN CHILDREN 1-YEAR AFTER BONE-MARROW TRANSPLANTATION, Oral Oncology, 33(5), 1997, pp. 327-331
SERUM LEVELS OF CYTOKINES AFTER BONE-MARROW TRANSPLANTATION - INCREASED IL-8 LEVELS DURING SEVERE VENOOCCLUSIVE DISEASE OF THE LIVER
Authors: REMBERGER M RINGDEN O
Citation: M. Remberger et O. Ringden, SERUM LEVELS OF CYTOKINES AFTER BONE-MARROW TRANSPLANTATION - INCREASED IL-8 LEVELS DURING SEVERE VENOOCCLUSIVE DISEASE OF THE LIVER, European journal of haematology, 59(4), 1997, pp. 254-262
TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE
Authors: RINGDEN P REMBERGER M MATTSSON J ASCHAN J HAGGLUND H LONNQVIST B SPARRELID E LJUNGMAN P
Citation: P. Ringden et al., TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE, Experimental hematology, 25(8), 1997, pp. 33-33
TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE
Authors: RINGDEN O REMBERGER M MATTSSON J ASCHAN J HAGGLUND H CARLENS S LONNQVIST B SPARRELID E LJUNGMAN P
Citation: O. Ringden et al., TRANSPLANTATION WITH UNRELATED BONE-MARROW IN LEUKEMIC PATIENTS ABOVE40 YEARS OF AGE, Transplantation proceedings, 29(7), 1997, pp. 3145-3146
FACTORS AFFECTING RISK OF RELAPSE AND LEUKEMIA-FREE SURVIVAL IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA
Authors: CARLENS S RINGDEN O REMBERGER M MATTSSON J ASCHAN J HAGGLUND H LJUNGMAN P
Citation: S. Carlens et al., FACTORS AFFECTING RISK OF RELAPSE AND LEUKEMIA-FREE SURVIVAL IN HLA-IDENTICAL SIBLING MARROW TRANSPLANT RECIPIENTS WITH LEUKEMIA, Transplantation proceedings, 29(7), 1997, pp. 3147-3149
Risultati: 1-25 | 26-50 | 51-57